The Substance Abuse and Mental Health Services Administration provides guidance for substance use disorder treatment services during the COVID-19 pandemic. The document specifies when a medical emergency exists, 42 C.F.R Part 2 does not apply and any disclosure of medical information is temporarily exempt for purposes of medical treatment.
The frequently asked questions document discusses how providers can provide Opioid Treatment to existing and new patients, and dispense medications via Telehealth while still meeting the 42 C.F.R. 8.11 requirements.
The frequently asked question document makes recommendations on how to care for patients during the COVID-19 pandemic in Mental Health Rehabilitation Centers and Psychiatric Health facilities. The recommendations suggest how to provide Telehealth services, and how to provide medical care for positive COVID-19 patients.
This document is a resource for behavioral health facilities to better understand how to treat patients and refer patients for medical care during the COVID-19 pandemic.
During the webinar, the presenter will focus on ways to address health equity issues and key considerations for providing linguistically effective services. The presenter will discuss best practices and models to support patients in these challenging times.
Understanding the brain chemistry associated with opioid use disorder treatment is essential: Medications for Addiction Treatment (MAT) restores depleted dopamine in the brain so people impacted by OUD can regain functioning. Recognizing this, therapy and support services for OUD are most effective when provided in accordance with a person's healing process and readiness to engage in treatment.
The American Society of Addiction Medicine (ASAM) has established specific criteria for patient assessments and level of care determinations pertaining to substance use disorder (SUD) – providing the underpinnings for effective treatment and recovery from addiction. This webinar will provide attendees with practical tools and tips for implementation of Screening Brief Intervention and Treatment (SBIRT) including assessments, workflows, and reimbursement.
This webinar will describe how stigma impacts perceptions and resultant SUD care for patients and providers alike. Presenters will also share key concepts and case studies to illustrate ways to address stigma and tools that can be incorporated into their clinical practice.
This webinar will focus on the benefits and outcomes of behavioral health integration and key implementation considerations. The presenters will discuss outcomes that include improving population health, patient experience and reduced costs. The webinar will also feature key integration tips such as building internal support, warm handoffs, establishing workflows among other topics.
This webinar will focus on the foundational concepts of health care integration – including physical and behavioral health – will be reviewed and discussed. The presenters will also focus on integrating substance use disorders and reverse integration.
